Stock News

Matarin Capital Management Has Upped By $612.36 Million Its Marriott Vacations Worldwide (VAC) Stake; Stemline Therapeutics Has 1.28 Sentiment

Marriott Vacations Worldwide Corporation (NYSE:VAC) Logo

Matarin Capital Management Llc increased Marriott Vacations Worldwide Corporation (VAC) stake by 2.85% reported in 2017Q4 SEC filing. Matarin Capital Management Llc acquired 4,529 shares as Marriott Vacations Worldwide Corporation (VAC)’s stock declined 1.00%. The Matarin Capital Management Llc holds 163,493 shares with $22.11 billion value, up from 158,964 last quarter. Marriott Vacations Worldwide Corporation now has $3.63 billion valuation. The stock increased 0.47% or $0.635 during the last trading session, reaching $136.615. About 17,004 shares traded. Marriott Vacations Worldwide Corporation (NYSE:VAC) has risen 39.79% since April 23, 2017 and is uptrending. It has outperformed by 28.24% the S&P500.

Stemline Therapeutics Inc (STML) investors sentiment increased to 1.28 in Q4 2017. It’s up 0.04, from 1.24 in 2017Q3. The ratio improved, as 37 investment managers started new and increased holdings, while 29 sold and decreased their holdings in Stemline Therapeutics Inc. The investment managers in our database reported: 14.38 million shares, up from 12.54 million shares in 2017Q3. Also, the number of investment managers holding Stemline Therapeutics Inc in top ten holdings increased from 0 to 1 for an increase of 1. Sold All: 11 Reduced: 18 Increased: 24 New Position: 13.

Lyon Street Capital Llc holds 4.31% of its portfolio in Stemline Therapeutics, Inc. for 829,090 shares. Consonance Capital Management Lp owns 2.35 million shares or 3.31% of their US portfolio. Moreover, Eventide Asset Management Llc has 0.88% invested in the company for 1.09 million shares. The Israel-based Sphera Funds Management Ltd. has invested 0.55% in the stock. Knott David M, a New York-based fund reported 74,992 shares.

Analysts await Stemline Therapeutics, Inc. (NASDAQ:STML) to report earnings on May, 9. They expect $-0.70 earnings per share, down 4.48% or $0.03 from last year’s $-0.67 per share. After $-0.93 actual earnings per share reported by Stemline Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -24.73% EPS growth.

The stock decreased 1.16% or $0.2 during the last trading session, reaching $17.1. About 46,339 shares traded. Stemline Therapeutics, Inc. (STML) has risen 79.53% since April 23, 2017 and is uptrending. It has outperformed by 67.98% the S&P500.

Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovering, acquiring, developing, and commercialization of proprietary oncology therapeutics in the United States. The company has market cap of $476.13 million. The firm develops SL-401, a targeted therapy directed to the interleukin-3 receptor , which is in Phase II clinical trial for patients with blastic plasmacytoid dendritic cell neoplasm, myeloproliferative neoplasms, and acute myeloid leukemia; and in Phase I clinical trial in combination with other agents for patients with relapsed/refractory multiple myeloma. It currently has negative earnings. It also develops SL-801, a novel oral small molecule reversible inhibitor of a tumor-promoting nuclear transport protein, which is in Phase I clinical trial for the treatment of solid and hematologic cancers; and SL-701, an immunotherapy that is in Phase II clinical trial to attack brain cancer.

Since January 1, 0001, it had 0 buys, and 14 insider sales for $2.80 million activity.

Since January 29, 2018, it had 0 insider purchases, and 3 selling transactions for $748,369 activity. Shares for $377,502 were sold by Yonker Michael E. on Thursday, March 1. Another trade for 1,250 shares valued at $183,250 was sold by Smith Dwight D..

Investors sentiment decreased to 0.9 in Q4 2017. Its down 0.01, from 0.91 in 2017Q3. It worsened, as 26 investors sold VAC shares while 82 reduced holdings. 38 funds opened positions while 59 raised stakes. 19.28 million shares or 0.64% less from 19.41 million shares in 2017Q3 were reported. Moreover, Prudential Fincl has 0.01% invested in Marriott Vacations Worldwide Corporation (NYSE:VAC) for 48,619 shares. Moreover, Suntrust Banks Inc has 0% invested in Marriott Vacations Worldwide Corporation (NYSE:VAC). Citadel Advsr Limited Liability has invested 0.01% in Marriott Vacations Worldwide Corporation (NYSE:VAC). 32,744 are held by Leuthold Group Inc Ltd Llc. Oppenheimer Asset Mngmt Inc reported 0.01% stake. 61,339 are held by Pathstone Family Office Ltd Liability Corp. Jane Street Grp Llc has invested 0% in Marriott Vacations Worldwide Corporation (NYSE:VAC). Panagora Asset Management invested 0% in Marriott Vacations Worldwide Corporation (NYSE:VAC). Campbell Investment Adviser Lc invested 1.23% in Marriott Vacations Worldwide Corporation (NYSE:VAC). Bamco Ny holds 1.35% or 2.16M shares in its portfolio. Toth Advisory holds 68 shares. Pub Employees Retirement Association Of Colorado accumulated 5,855 shares or 0.01% of the stock. Shell Asset Mngmt invested 0.04% in Marriott Vacations Worldwide Corporation (NYSE:VAC). Envestnet Asset Inc reported 1,609 shares. Raymond James Financial Serv Advsr reported 0% in Marriott Vacations Worldwide Corporation (NYSE:VAC).

Matarin Capital Management Llc decreased Lpl Financial Holdings Inc. (NASDAQ:LPLA) stake by 2,272 shares to 22,762 valued at $1.30 billion in 2017Q4. It also reduced Shiloh Industries Inc. (NASDAQ:SHLO) stake by 1,371 shares and now owns 110,190 shares. Sysco Corporation (NYSE:SYY) was reduced too.

Among 10 analysts covering Marriot Vacations Worldwide (NYSE:VAC), 6 have Buy rating, 0 Sell and 4 Hold. Therefore 60% are positive. Marriot Vacations Worldwide had 27 analyst reports since July 24, 2015 according to SRatingsIntel. The stock has “Buy” rating by Nomura on Friday, November 3. The firm has “Buy” rating given on Friday, April 29 by M Partners. The firm earned “Buy” rating on Friday, July 24 by M Partners. The rating was maintained by Telsey Advisory Group with “Market Perform” on Friday, February 24. The firm earned “Buy” rating on Thursday, February 1 by Stifel Nicolaus. The rating was maintained by M Partners with “Buy” on Friday, October 16. The stock has “Hold” rating by SunTrust on Tuesday, February 27. The company was maintained on Monday, January 11 by Stifel Nicolaus. The stock of Marriott Vacations Worldwide Corporation (NYSE:VAC) has “Buy” rating given on Monday, September 25 by Stifel Nicolaus. The stock of Marriott Vacations Worldwide Corporation (NYSE:VAC) earned “Buy” rating by Stifel Nicolaus on Tuesday, September 19.

Marriott Vacations Worldwide Corporation (NYSE:VAC) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *